Family, Responsibility, Education, Support, and Health for Food Responsiveness
ConditionObesity, Childhood
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age7-12
SponsorUniversity of California, San Diego
About this trial
The objective of this proposed study is to compare Regulation of Cues (ROC), Family-Based Treatment (FBT), ROC+ nutrition education and reducing energy intake (ROC+) and a health education comparator (HE) for children with overweight or obesity who are high on food responsiveness (FR).
Eligibility criteria
Qualifiers
Informed assent and parental consent
A child with overweight or obesity (≥ 85th BMI%) aged 7-12 years of age
Child high on FR - High FR will be measured by the Food Responsiveness Scale via the CEBQ, with scores at a 3.8 or higher constituting a child with high FR.
A parent responsible for food preparation who is willing to participate and can read, speak and understand English at a minimum of a 5th grade level
Disqualifiers
Acute child psychiatric disorder diagnoses (e.g., acute suicidality, recent hospitalization, psychosis, bulimia nervosa)
Child diagnoses of a serious chronic physical disease (e.g., cystic fibrosis, type 1 diabetes) for which physician supervision of diet and exercise prescription may be warranted
Child who is taking medication for weight loss
Acute parent psychiatric disorder (e.g., acute suicidality; recent hospitalization; psychosis, bipolar disorder, borderline personality disorder, moderate or severe alcohol or substance use disorder)
Trial design
Treatments tested in this trial
- Regulation of Cues
- Family Based Behavioral Treatment
- Regulation of Cues +
- Health Education
Treatment groups
280 Participants
are divided into 4 treatment groupsLocations
2UC San Diego Center for Healthy Eating and Activity Research (CHEAR)92037, La JollaCalifornia, United States
Ambulatory Research Center - University of Minnesota55454, MinneapolisMinnesota, United States
Sponsors and collaborators
University of California, San Diego
Lead sponsor
University of Minnesota
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Source ClinicalTrials.gov